97 related articles for article (PubMed ID: 17364114)
1. Unstable angina patients treated with percutaneous coronary intervention in the new millennium: what characterizes them?
Peixoto Dda S; Tanajura LF; Sousa AG; Centemero MP; Chaves AJ; Maia Jde P; Fonseca AG; Piva e Mattos LA; Feres F; Sousa JE
Arq Bras Cardiol; 2007 Jan; 88(1):26-30. PubMed ID: 17364114
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of early percutaneous coronary intervention in patients with Braunwald III-B type unstable angina pectoris].
Nozaki K; Nakao K; Horiuchi K; Kasanuki H; Honda T
J Cardiol; 2003 Jun; 41(6):263-70. PubMed ID: 12845880
[TBL] [Abstract][Full Text] [Related]
3. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
Breeman A; Mercado N; Lenzen M; van den Brand MM; Harrington RA; Califf RM; Topol EJ; Simoons ML; Boersma E;
Cardiology; 2002; 98(4):195-201. PubMed ID: 12566649
[TBL] [Abstract][Full Text] [Related]
4. Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention.
Palmer ND; Causer JP; Ramsdale DR; Perry RA
J Invasive Cardiol; 2004 Apr; 16(4):185-8. PubMed ID: 15152143
[TBL] [Abstract][Full Text] [Related]
5. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
Bosch X; Marrugat J
Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
7. Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome.
Marzocchi A; Ortolani P; Piovaccari G; Marrozzini C; Nobile G; Palmerini T; Marinucci L; Saia F; Bacchi Reggiani ML; Branzi A; Magnani B
Coron Artery Dis; 1999; 10(2):81-8. PubMed ID: 10219513
[TBL] [Abstract][Full Text] [Related]
8. Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.
Brener SJ; Ertelt K; Mehran R; Genereux P; Xu K; Witzenbichler B; Brodie BR; Guagliumi G; Stone GW
Am Heart J; 2015 Feb; 169(2):242-8. PubMed ID: 25641533
[TBL] [Abstract][Full Text] [Related]
9. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of stent implantation versus stent-like angioplasty in unstable angina.
Marzocchi A; Ortolani P; Piovaccari G; Marrozzini C; Palmerini T; Marinucci L; Saia F; Bacchi-Reggiani ML; Branzi A; Magnani B
Cardiologia; 1999 Mar; 44(3):261-8. PubMed ID: 10327728
[TBL] [Abstract][Full Text] [Related]
11. Coronary angioplasty in patients with unstable angina: clinical, electrocardiographic and angiographic predictors of in-hospital outcome. R.OS.A.I. Study Group.
Dellavalle A; De Servi S; Repetto S; Chierchia S; Repetto A; Vado A; Steffenino G
Ital Heart J; 2000 Aug; 1(8):555-61. PubMed ID: 10994937
[TBL] [Abstract][Full Text] [Related]
12. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
13. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
[TBL] [Abstract][Full Text] [Related]
14. Stent thrombosis in patients treated with thienopyridines: clinical description of 10 cases.
Michowitz Y; Blatt A; Frimmerman A; Finkelstein A; Massachi R; Herz I; Krakover R; Miller H; Keren G; George J
Int J Cardiovasc Intervent; 2004; 6(3-4):160-4. PubMed ID: 16146913
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
Bounhoure JP; Farah B; Fajadet J; Marco J
Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Popma JJ; Berger P; Ohman EM; Harrington RA; Grines C; Weitz JI
Chest; 2004 Sep; 126(3 Suppl):576S-599S. PubMed ID: 15383485
[TBL] [Abstract][Full Text] [Related]
18. Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.
De Servi S; Mariani M; Vandoni P; Dellavalle A; Politi A; Poletti F; Bonizzoni E; Leoncinie M;
J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):159-65. PubMed ID: 16645379
[TBL] [Abstract][Full Text] [Related]
19. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
Am J Cardiol; 2013 May; 111(10):1377-86. PubMed ID: 23465098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
